Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Status unconfirmed · Phase 3 · Has a placebo group
Conditions studied: Migraine
In brief
The purpose of the study is to determine the effect of intranasal lidocaine on pain score in pediatric patients with migraine. Patients with significant pain after oral analgesics and plan for intravenous (IV) abortive therapy will be asked to participate. Half of patients will be given intranasal lidocaine and the other half will be given placebo. Pain scores and associated migraine symptoms (i.e. nausea, vomiting, photophobia, phonophobia, avoidance of activities, and aura) will be monitored and compared between the groups.
Key facts
- Study ID
- NCT03576820
- Run by
- New York City Health and Hospitals Corporation
- People needed
- 50
- Starts
- 2018-10-15
- Expected to finish
- 2022-12-01
- Last updated by the study team
- 2021-01-05
Who can join
Age: 10 and older, up to 20. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients who will be receiving IV metoclopramide because their migraine is refractory to oral analgesics, as determined by the treating physician.
- Moderate to severe headache with NRS score greater than or equal to 6
- Headache lasting between 2-72 hours
- Two of the following:
- non-occipital location of headache (frontal, frontotemporal, or unilateral)
- pulsating or throbbing quality
- aggravated by or causing avoidance of routine physical activity
- nausea, vomiting, or both
- photophobia and/or phonophobia (may be inferred from behavior)
You may not qualify if…
- unstable vital signs
- pregnancy
- lactating
- altered mental status
- developmental delay
- intractable vomiting
- first-time headache
- history of cardiac arrythmia
- previous adverse reaction or allergy to lidocaine
- non-English speaking
Where it is running
- Jacobi Medical Center — The Bronx, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.